Debiopharm International SA: Series A financing round lays foundation for international growth of digital cancer therapeutics Mika

New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika - an app-based DTx platform empowering

Related Keywords

Germany ,Leipzig ,Sachsen ,Munich ,Bayern ,United Kingdom ,Switzerland ,Spain ,Berlin ,Barcelona ,Comunidad Autonoma De Cataluna ,Swiss ,Gandolf Finke ,Tanja Dowe ,Andrea Buhofer ,Bernd Klosterkemper ,Directordr Gandolf Finke ,Dtx Mika ,Kostenloser Wertpapierhandel ,Maite Fibla ,Fosanis Gmb ,Digital Health ,Mika Co ,University Of Leipzig Medical Center ,World Health Organization ,Smart Data Digital Health ,Debiopharm Innovation Fund ,German Digital Therapeutics ,Ananda Impact Ventures ,Mika Founder ,Managing Director Dr Jan Simon ,Managing Directordr Gandolf Finke ,Managing Partner ,Equitypitcher Ventures ,Impact Ventures ,Fosanis Gmbh ,Leipzig Medical Center ,Innovation Fund ,Smart Data ,Rosita Longevity ,Venture Capital ,Debiopharm ,Nternational ,Series ,Financing ,Hound ,Ways ,Foundation ,Growth ,Digital ,Dancer ,Herapeutics ,Mika ,